NextPlat Corp Common Stock

NextPlat Corp Common Stock Earnings Recaps

NXPL Information Technology 2 recaps
Next earnings: March 30, 2027 (estimated) · full calendar
Q3 2026 Nov 15, 2026

NextPlat shares fell 15.3% after the earnings release, with the transcript pointing to ongoing pressure in retail pharmacy revenue and a sequential $0.3 million decline in medication-fulfillment contracts after a customer closed a facility. Management also delayed the healthcare e-commerce launch to this month, tempering the turnaround narrative despite year-over-year improvement in margins and operating losses.

Key takeaways
  • Contracted pharmacy revenue was nearly 300% higher year over year, but one customer’s facility closure reduced medication-fulfillment revenue by about $0.3 million sequentially.
  • Total pharmacy prescription revenue declined year over year, reflecting lower payer reimbursement rates, fewer prescriptions, and payer mix.
  • NextPlat added three 340B contracts in the quarter, bringing the annual total to 14; management said onboarding typically takes around 90 days.
  • The Scott’s Pharmacy acquisition is expected to contribute about $1.2 million in quarterly revenue and $150,000 in net profit during Q4, based on current activity.
  • The healthcare e-commerce site launch slipped from the expected Q3 timing and is now expected this month.
Q3 2025 Nov 13, 2025

NextPlat Corp's Q3 2025 earnings reflect ongoing operational challenges, but improvements in revenue and cost management signal a positive trajectory moving into 2026.

Key takeaways
  • Introduction of successful business development initiatives has started to yield significant revenue and profitability improvements, particularly in the Healthcare segment.
  • E-commerce and communications segments saw robust sales, particularly in satellite-based connectivity products and high-margin recurring revenues.
  • Optimism around the 340B business line, which has shown a strong rebound and improved customer engagement in recent months.
  • Payroll savings of approximately $200,000 monthly achieved through headcount reductions, indicating ongoing cost management efforts.
  • Strategic leadership changes, including a new CFO and VP of Healthcare Operations, aimed at enhancing operational effectiveness.